HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New drugs 09, part 2.

Abstract
In this article, you'll learn about six new drugs, including: * clevidipine, an I.V. antihypertensive for use when oral medication isn't feasible * romiplostim and eltrombopag olamine, new agents for chronic immune thrombocytopenic purpura * C1 inhibitor (human) for hereditary angioedema. Unless otherwise specified, the information in the following summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breast-feeding. Also consult a pharmacist, the package insert, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions for all these drugs.
AuthorsDaniel A Hussar
JournalPlastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses (Plast Surg Nurs) 2009 Oct-Dec Vol. 29 Issue 4 Pg. 239-44; quiz 245-6 ISSN: 1550-1841 [Electronic] United States
PMID20029305 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic Uptake Inhibitors
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Hematologic Agents
  • Immunologic Factors
Topics
  • Adrenergic Uptake Inhibitors
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Drug Monitoring (nursing)
  • Hematologic Agents
  • Humans
  • Immunologic Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: